Celsius Holdings, Inc. CELH
We take great care to ensure that the data presented and summarized in this overview for Celsius Holdings, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CELH
View all-
Vanguard Group Inc Valley Forge, PA15.8MShares$552 Million0.01% of portfolio
-
Black Rock Inc. New York, NY15.5MShares$542 Million0.02% of portfolio
-
Alliancebernstein L.P. New York, NY14.3MShares$499 Million0.13% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL6.88MShares$240 Million0.73% of portfolio
-
State Street Corp Boston, MA5.19MShares$181 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY4.73MShares$165 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.03MShares$141 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$140 Million0.01% of portfolio
-
Morgan Stanley New York, NY3.34MShares$117 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT3.23MShares$113 Million0.56% of portfolio
Latest Institutional Activity in CELH
Top Purchases
Top Sells
About CELH
Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional drinks and liquid supplements in North America, Europe, Asia, and internationally. It offers various carbonated and non-carbonated functional energy drinks under the CELSIUS Originals name; dietary supplement in carbonated flavors, including apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit under the CELSIUS HEAT name; and branched-chain amino acids functional energy drink that fuels muscle recovery under the CELSIUS BCCA+ENERGY name. The company also provides CELSIUS On-the-Go, a powdered form of the active ingredients in functional energy drinks in individual On-The-Go packets and canisters; and sparkling grapefruit, cucumber lime, and orange pomegranate, as well as pineapple coconut, watermelon berry, and strawberries and cream non-carbonated functional energy drinks under the CELSIUS Sweetened. It distributes its products through direct-to-store delivery distributors and direct to retailers, including supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.
Insider Transactions at CELH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 11
2025
|
Caroline S Levy Director |
SELL
Open market or private sale
|
Direct |
70,000
-62.08%
|
$1,820,000
$26.84 P/Share
|
Mar 11
2025
|
Caroline S Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
70,000
+38.3%
|
$280,000
$4.84 P/Share
|
Mar 11
2025
|
Joyce Russell Director |
SELL
Open market or private sale
|
Direct |
4,000
-17.31%
|
$112,000
$28.47 P/Share
|
Mar 06
2025
|
Paul H. Storey Chief Supply Chain Officer |
SELL
Open market or private sale
|
Direct |
10,188
-18.36%
|
$254,700
$25.77 P/Share
|
Mar 01
2025
|
Paul H. Storey Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,392
+24.9%
|
-
|
Mar 01
2025
|
Paul H. Storey Chief Supply Chain Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-2.35%
|
$22,350
$25.69 P/Share
|
Mar 01
2025
|
Jarrod Langhans Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,335
+20.9%
|
-
|
Mar 01
2025
|
Jarrod Langhans Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,490
-1.68%
|
$37,250
$25.69 P/Share
|
Mar 01
2025
|
Hans Mj Melotte Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,865
+41.98%
|
-
|
Mar 01
2025
|
Joyce Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,865
+17.39%
|
-
|
Mar 01
2025
|
Richard Stephen Mattessich Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,392
+35.5%
|
-
|
Mar 01
2025
|
Richard Stephen Mattessich Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,015
-6.33%
|
$25,375
$25.69 P/Share
|
Mar 01
2025
|
Caroline S Levy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,865
+10.22%
|
-
|
Mar 01
2025
|
Damon De Santis Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,865
+0.18%
|
-
|
Mar 01
2025
|
Cheryl Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,865
+18.38%
|
-
|
Mar 01
2025
|
Hal Kravitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,865
+2.31%
|
-
|
Mar 01
2025
|
Kyle Audrey Watson Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,392
+17.05%
|
-
|
Mar 01
2025
|
Kyle Audrey Watson Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
894
-1.24%
|
$22,350
$25.69 P/Share
|
Mar 01
2025
|
John Fieldly Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,985
+5.31%
|
-
|
Mar 01
2025
|
John Fieldly Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,482
-0.2%
|
$62,050
$25.69 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 273K shares |
---|---|
Exercise of conversion of derivative security | 1.73M shares |
Bona fide gift | 8.53M shares |
Sale (or disposition) back to the issuer | 18K shares |
---|---|
Payment of exercise price or tax liability | 70.9K shares |
Open market or private sale | 9.89M shares |
Bona fide gift | 14.4M shares |